Michael Artinger

CEO & Board Member at Neurexis Therapeutics

The focus of Dr. Artinger’s career has been transforming innovation into commercial opportunity. He has worked closely with universities and inventors across the nation to recognize the potential of their discoveries and has deep expertise across multiple operational roles and domains.

Dr. Artinger has over 23 years of operational experience in the life science industry and as been involved in the preclinical and clinical development of therapeutics and vaccines across multiple therapeutic areas. He has held appointments as Visiting Scientist in Medicine at both Harvard Medical School and Brigham and Women’s Hospital, and conducted his Postdoctoral research at the Cardiovascular Research Center at Massachusetts General Hospital and Harvard Medical School.

Dr. Artinger earned his Doctorate degree in Biology focusing on Developmental and Cell Biology, as well as his Baccalaureate degree in Applied Ecology from the University of California at Irvine.

Location

Minneapolis, United States

Links

Previous companies


Org chart


Teams

This person is not in any teams


Offices

This person is not in any offices


Neurexis Therapeutics

Neurexis is developing an optimized peptide with demonstrated efficacy and safety in small and large animal models of global cerebral ischemia.


Industries

Employees

1-10

Links